We found 302 cardiac effects including 94 bradycardia (31%) among the 2603 reports with remdesivir prescribed in COVID-19 patients. Most of the 94 reports were serious (75, 80%), and in 16 reports (17%) evolution was fatal. Compared with hydroxychloroquine, lopinavir/ritonavir, tocilizumab
(www.clinicalmicrobiologyandinfection.com)
You're viewing a single comment thread. View all comments, or full comment thread.
Comments (2)
sorted by:
Refutes the bogus story rushed out by Lancet and NEJM that said HCQ had heart risks. Meant to prop up Fauci pushing Remdesvir, which has worse heart effects, thus a few more notches on Fauci's kill stick.